ARCHIVES

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Moves Ahead With Trials Database, Reporting Studies In Progress At Cancer Centers

July 15, 2011

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

NCI Supports Development Of Reinoids for Prevention; No Magic Bullet

May 6, 1977

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007

NCI Budget Picture: New Grants Down, No New Center Awards, Many Projects Left Unfunded

December 10, 1976